Therapeutic drug monitoring and safety evaluation of voriconazole in the treatment of pulmonary fungal diseases

伏立康唑 医学 内科学 不利影响 治疗药物监测 入射(几何) 相伴的 药代动力学 药理学 胃肠病学 抗真菌 物理 皮肤病科 光学
作者
Kunlu Shen,Yu Gu,Yu Wang,Yajie Lu,Yueyan Ni,Huanhiuan Zhong,Yi Shi,Xin Su
出处
期刊:Therapeutic advances in drug safety [SAGE Publishing]
卷期号:13 被引量:19
标识
DOI:10.1177/20420986221127503
摘要

The gene polymorphism of voriconazole metabolism-related liver enzyme is notable in East Asia population. It casts a significant influence on the rational use of voriconazole. We conducted this study to investigate the relationship between steady-state voriconazole trough concentration (Ctrough) and adverse effects (AEs), especially hepatotoxicity.We conducted a real-world study in the Jinling Hospital from January 2015 to June 2020. A total of 140 patients receiving voriconazole were enrolled in this study. The determination and scoring of voriconazole-associated hepatotoxicity were performed according to the Roussel Uclaf Causality Assessment Method scoring scale and the severity of hepatotoxicity was graded according to the Common Terminology Criteria for Adverse Events (CTCAE).Elevated steady-state voriconazole Ctrough with concomitant AEs are the most common reason for dose adjustments during treatment. Compared with the group without any AEs, voriconazole Ctrough was significantly higher in the hepatotoxicity and neurotoxicity groups, and the incidence of both events showed an overall increasing trend with increasing voriconazole Ctrough. Hepatotoxicity occurred in 66.7% of patients within 7 days of the first dose of voriconazole and 94.4% within 15 days of the dose. Steady-state voriconazole Ctrough >3.61 mg/l was associated with an increased incidence of hepatotoxicity (area under the curve = 0.645, p = 0.047). Logistic regression analysis showed that timely voriconazole dose adjustment was a predictor of attenuated hepatotoxicity after adjustment for confounders, but hepatotoxicity was not associated with voriconazole Ctrough measured at a single time point.Hepatotoxicity and neurotoxicity correlate with voriconazole Ctrough, and dose reduction in patients with elevated steady-state voriconazole Ctrough may prevent hepatotoxicity. In patients with early occurrence of hepatotoxicity, initial therapeutic drug monitoring (TDM) might predict the risk of hepatotoxicity. Follow-up TDM may be necessary to predict late onset hepatotoxicity.Safety of voriconazole for the treatment of pulmonary fungal diseasesIntroduction: Several studies have suggested an association between the concentration of voriconazole in the blood and liver damage, but the evidence is weak. This study aimed to investigate relationships between voriconazole drug concentration and side effects and to analyze the factors affecting liver damage caused by voriconazole.Methods: We conducted a study at the Jinling Hospital from January 2015 to June 2020, in which a total of 140 patients were finally enrolled.Results: Voriconazole doses were adjusted in 44 patients due to abnormal voriconazole drug concentration or side effects, 32 patients reduced the dose and 8 patients increased the dose. An elevated liver enzyme level was the most common cause for dose adjustment. After the first dose adjustment, most patients achieved the target drug concentration. A total of 18 patients were determined as probable or highly probable to have drug-induced liver injury from voriconazole. Voriconazole drug concentration was significantly higher in the liver damage and nervous system damage groups as compared with the group without any side effects, and most liver damage events occurred within 14 days of the first dose. Voriconazole drug concentration >3.61 mg/l was associated with an increased incidence of liver damage.Conclusion: In this study, approximately one-third of patients with pulmonary fungal disease needed to adjust their dose after the standard dose of voriconazole treatment. The incidence of liver damage and nervous system damage showed an overall increasing trend with increasing voriconazole baseline concentrations. Initial therapeutic drug monitoring may be predictive of liver damage. Follow-up monitoring of liver enzymes may be needed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
斯文如娆发布了新的文献求助30
1秒前
只争朝夕的应助被可妍昇采纳,获得10
1秒前
1秒前
CipherSage的应助被qyt采纳,获得10
2秒前
2秒前
2秒前
2秒前
奋斗若风完成签到,获得积分10
4秒前
zjq4302完成签到,获得积分10
4秒前
ZZZZZZZZ完成签到,获得积分10
4秒前
4秒前
XINGCHEN完成签到 ,获得积分10
4秒前
5秒前
5秒前
Xxxy完成签到 ,获得积分10
5秒前
5秒前
6秒前
wjw完成签到,获得积分10
7秒前
风信子完成签到,获得积分10
7秒前
7秒前
7秒前
苏丽妃完成签到 ,获得积分10
7秒前
情怀的应助被jc哥采纳,获得10
7秒前
Zz发布了新的文献求助20
7秒前
Elige完成签到,获得积分10
7秒前
孙淳完成签到,获得积分10
7秒前
yan发布了新的文献求助10
7秒前
所所的应助被liquidwy采纳,获得10
8秒前
汉堡包的应助被白白采纳,获得10
8秒前
俞佳美发布了新的文献求助10
8秒前
ylva完成签到,获得积分10
8秒前
plemon完成签到,获得积分10
9秒前
圆圆完成签到,获得积分10
9秒前
unqiue的应助被荼蘼采纳,获得10
9秒前
元吉的应助被荼蘼采纳,获得10
9秒前
Ximilu发布了新的文献求助10
9秒前
我是老大的应助被荼蘼采纳,获得10
9秒前
heady发布了新的文献求助10
9秒前
明理的千筹发布了新的文献求助100
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180927
求助须知:如何正确求助?哪些是违规求助? 9570973
关于积分的说明 21815578
捐赠科研通 7777227
什么是DOI,文献DOI怎么找? 3433367
关于科研通互助平台的介绍 2557621
邀请新用户注册赠送积分活动 2479346